Pluripotent stem cell-derived pancreatic -cells: Potential for regenerative medicine in diabetes

Regenerative Medicine

Volumn 7, Issue 4, 2012, Pages 583-593

  Kao, Der I ^a   Chen, Shuibing ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

cell replacement therapy; chemical screening; diabetes; disease modeling; human embryonic stem cell; human induced pluripotent stem cell; pancreatic cell; stepwise differentiation

Indexed keywords

INDOLACTAM V; PROTEIN IDE1; PROTEIN IDE2; REGULATOR PROTEIN; STAUPIRIMIDE; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL FUNCTION; CELL THERAPY; DIABETES MELLITUS; GENETIC ASSOCIATION; HUMAN; NONHUMAN; PANCREAS ISLET BETA CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SIGNAL TRANSDUCTION; STEM CELL NICHE; STEM CELL TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; DIABETES MELLITUS; HUMANS; INSULIN-SECRETING CELLS; PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION;

EID: 84864242988     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.12.27     Document Type: Review

References (83)

1. Brook CGD, Brown RS. Handbook of Clinical Pediatric Endocrinology (1st Edition). Blackwell Publishing, MA, USA (2008).
2. Lonovics J, Devitt P, Watson LC, Rayford PL, Thompson JC. Pancreatic polypeptide. A review. Arch. Surg. 116(10), 1256-1264 (1981).
3. Inui A, Asakawa A, Bowers CY et al. Ghrelin, appetite, and gastric motility: The emerging role of the stomach as an endocrine organ. FASEB J. 18(3), 439-456 (2004). (Pubitemid 38326301)
4. Ashcroft FM, Rorsman P. Diabetes mellitus and the beta cell: The last ten years. Cell 148(6), 1160-1171 (2012).
5. Cooke DW, Plotnick L. Type 1 diabetes mellitus in pediatrics. Pediatr. Rev. 29(11), 374-385 (2008).
6. Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53(Suppl. 3), S16-S21 (2004). (Pubitemid 39564517)
7. Lakey JR, Burridge PW, Shapiro AM. Technical aspects of islet preparation and transplantation. Transpl. Int. 16(9), 613-632 (2003). (Pubitemid 37203410)
8. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with Type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343(4), 230-238 (2000). (Pubitemid 30490390)
9. Pan FC, Wright C. Pancreas organogenesis: From bud to plexus to gland. Dev. Dyn. 240(3), 530-565 (2011).
10. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development. Cell 132(4), 661-680 (2008). (Pubitemid 351260059)
11. Stainier DY. A glimpse into the molecular entrails of endoderm formation. Genes Dev. 16(8), 893-907 (2002). (Pubitemid 34408539)
12. D'Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 23(12), 1534-1541 (2005). (Pubitemid 41752931)
13. D'Amour KA, Bang AG, Eliazer S et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 24(11), 1392-1401 (2006). (Pubitemid 44722103)
14. Ku HT, Zhang N, Kubo A et al. Committing embryonic stem cells to early endocrine pancreas in vitro. Stem Cells 22(7), 1205-1217 (2004). (Pubitemid 39636399)
15. McLean AB, D'Amour KA, Jones KL et al. Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem Cells 25(1), 29-38 (2007). (Pubitemid 46052972)
16. Gu G, Brown JR, Melton DA. Direct lineage tracing reveals the ontogeny of pancreatic cell fates during mouse embryogenesis. Mech. Dev. 120(1), 35-43 (2003). (Pubitemid 35462094)
17. Jonsson J, Carlsson L, Edlund T, Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371(6498), 606-609 (1994). (Pubitemid 24315741)
18. Offield MF, Jetton TL, Labosky PA et al. Pdx-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122(3), 983-995 (1996). (Pubitemid 26096002)
19. Stafford D, Prince VE. Retinoic acid signaling is required for a critical early step in zebrafish pancreatic development. Curr. Biol. 12(14), 1215-1220 (2002). (Pubitemid 34801169)
20. Tiso N, Filippi A, Pauls S, Bortolussi M, Argenton F. BMP signalling regulates anteroposterior endoderm patterning in zebrafish. Mech. Dev. 118(1-2), 29-37 (2002). (Pubitemid 35292119)
21. Roy S, Qiao T, Wolff C, Ingham PW. Hedgehog signaling pathway is essential for pancreas specification in the zebrafish embryo. Curr. Biol. 11(17), 1358-1363 (2001). (Pubitemid 32835877)
22. Bhushan A, Itoh N, Kato S et al. FGF10 is essential for maintaining the proliferative capacity of epithelial progenitor cells during early pancreatic organogenesis. Development 128(24), 5109-5117 (2001). (Pubitemid 34083036)
23. Hart A, Papadopoulou S, Edlund H. FGF10 maintains notch activation, stimulates proliferation, and blocks differentiation of pancreatic epithelial cells. Dev. Dyn. 228(2), 185-193 (2003). (Pubitemid 37193631)
24. Jiang W, Shi Y, Zhao D et al. In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Res. 17(4), 333-344 (2007). (Pubitemid 46639938)
25. Kroon E, Martinson LA, Kadoya K et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 26(4), 443-452 (2008). (Pubitemid 351501814)
26. Kunisada Y, Tsubooka-Yamazoe N, Shoji M, Hosoya M. Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells. Stem Cell Res. 8(2), 274-284 (2012).
27. Kelly OG, Chan MY, Martinson La et al. Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. Nat. Biotechnol. 29(8), 750-756 (2011).
28. Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage: ngn3+ cells are islet progenitors and are distinct from duct progenitors. Development 129(10), 2447-2457 (2002). (Pubitemid 34863851)
29. Lee JC, Smith SB, Watada H et al. Regulation of the pancreatic pro-endocrine gene neurogenin3. Diabetes 50(5), 928-936 (2001). (Pubitemid 32374521)
30. Apelqvist A, Li H, Sommer L et al. Notch signalling controls pancreatic cell differentiation. Nature 400(6747), 877-881 (1999). (Pubitemid 29406724)
31. Jensen J, Pedersen EE, Galante P et al. Control of endodermal endocrine development by Hes-1. Nat. Genet. 24(1), 36-44 (2000). (Pubitemid 30041417)
32. Nostro MC, Sarangi F, Ogawa S et al. Stage-specific signaling through TGFbeta family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development 138(5), 861-871 (2011).
33. Stoffers DA, Kieffer TJ, Hussain MA et al. Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 49(5), 741-748 (2000). (Pubitemid 30339989)
34. Leibiger IB, Leibiger B, Berggren PO. Insulin signaling in the pancreatic beta-cell. Ann. Rev. Nutr. 28, 233-251 (2008).
35. Elghazi L, Rachdi L, Weiss AJ, Cras-Meneur C, Bernal-Mizrachi E. Regulation of beta-cell mass and function by the Akt/protein kinase B signalling pathway. Diabetes Obes. Metab. 9(Suppl. 2), 147-157 (2007). (Pubitemid 47543137)
36. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and Type 2 diabetes. Nature 444(7121), 840-846 (2006). (Pubitemid 46024990)
37. Hang Y, Stein R. MafA and MafB activity in pancreatic beta cells. Trends Endocrinol. Metab. 22(9), 364-373 (2011).
38. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455(7213), 627-632 (2008).
39. Blum B, Hrvatin SS, Schuetz C, Bonal C, Rezania A, Melton DA. Functional beta-cell maturation is marked by an increased glucose threshold and by expression of urocortin 3. Nat. Biotechnol. 30(3), 261-264 (2012).
40. Zhu S, Wurdak H, Wang J et al. A small molecule primes embryonic stem cells for differentiation. Cell Stem Cell 4(5), 416-426 (2009).
41. Borowiak M, Maehr R, Chen S et al. Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Cell Stem Cell 4(4), 348-358 (2009).
42. Chen S, Borowiak M, Fox JL et al. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat. Chem. Biol. 5(4), 258-265 (2009).
43. Maehr R, Chen S, Snitow M et al. Generation of pluripotent stem cells from patients with Type 1 diabetes. Proc. Natl Acad. Sci. USA 106(37), 15768-15773 (2009).
44. Thatava T, Nelson TJ, Edukulla R et al. Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny. Gene Ther. 18(3), 283-293 (2011).
45. Tateishi K, He J, Taranova O, Liang G, D'Alessio AC, Zhang Y. Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J. Biol. Chem. 283(46), 31601-31607 (2008).
46. Santamaria P, Rodriguez-Piza I, Clemente- Casares X et al. Turning human epidermis into pancreatic endoderm. Rev. Diabet. Stud. 7(2), 158-167 (2010).
47. Alipio Z, Liao W, Roemer EJ et al. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc. Natl Acad. Sci. USA 107(30), 13426-13431 (2010).
48. Zhu FF, Zhang PB, Zhang DH et al. Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells. Diabetologia 54(9), 2325-2336 (2011).
49. Tang C, Lee AS, Volkmer JP et al. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat. Biotechnol. 29(9), 829-834 (2011).
50. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 322(5903), 945-949 (2008).
51. Yu J, Hu K, Smuga-Otto K et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324(5928), 797-801 (2009).
52. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458(7239), 771-775 (2009).
53. Warren L, Manos PD, Ahfeldt T et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7(5), 618-630 (2010).
54. Zhou H, Wu S, Joo JY et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4(5), 381-384 (2009).
55. Nikolova G, Jabs N, Konstantinova I et al. The vascular basement membrane: A niche for insulin gene expression and beta cell proliferation. Dev. Cell 10(3), 397-405 (2006).
56. Eberhard D, Kragl M, Lammert E. 'Giving and taking': Endothelial and beta-cells in the islets of Langerhans. Trends Endocrinol. Metab. 21(8), 457-463 (2010).
57. Ito T, Itakura S, Todorov I et al. Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function. Transplantation 89(12), 1438-1445 (2010).
58. Cheng Y, Liu YF, Zhang JL, Li TM, Zhao N. Elevation of vascular endothelial growth factor production and its effect on revascularization and function of graft islets in diabetic rats. World J. Gastroenterol. 13(20), 2862-2866 (2007). (Pubitemid 47007904)
59. Cheng K, Fraga D, Zhang C et al. Adenovirus-based vascular endothelial growth factor gene delivery to human pancreatic islets. Gene Ther. 11(14), 1105-1116 (2004). (Pubitemid 39117306)
60. Cheng JY, Raghunath M, Whitelock J, Poole-Warren L. Matrix components and scaffolds for sustained islet function. Tissue Eng. Part B Rev. 17(4), 235-247 (2011).
61. Stendahl JC, Kaufman DB, Stupp SI. Extracellular matrix in pancreatic islets: Relevance to scaffold design and transplantation. Cell Transplant. 18(1), 1-12 (2009).
62. Basta G, Montanucci P, Luca G et al. Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with Type 1 diabetes treated with microencapsulated islet allografts: Four cases. Diabetes Care 34(11), 2406-2409 (2011).
63. Sakata N, Sumi S, Yoshimatsu G, Goto M, Egawa S, Unno M. Encapsulated islets transplantation: Past, present and future. World J. Gastrointest. Pathophysiol. 3(1), 19-26 (2012).
64. Lee G, Papapetrou EP, Kim H et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461(7262), 402-406 (2009).
65. Carvajal-Vergara X, Sevilla A, D'Souza SL et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465(7299), 808-812 (2010).
66. Urbach A, Bar-Nur O, Daley GQ, Benvenisty N. Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 6(5), 407-411 (2010).
67. Liu GH, Barkho BZ, Ruiz S et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 472(7342), 221-225 (2011).
68. Itzhaki I, Maizels L, Huber I et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471(7337), 225-229 (2011).
69. Nguyen HN, Byers B, Cord B et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8(3), 267-280 (2011).
70. Soldner F, Hockemeyer D, Beard C et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136(5), 964-977 (2009).
71. Dimos JT, Rodolfa KT, Niakan KK et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321(5893), 1218-1221 (2008).
72. Ebert AD, Yu J, Rose FF Jr et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457(7227), 277-280 (2009).
73. Marchetto MC, Carromeu C, Acab A et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143(4), 527-539 (2010).
74. Yazawa M, Hsueh B, Jia X et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 471(7337), 230-234 (2011).
75. Rashid ST, Corbineau S, Hannan N et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J. Clin. Invest. 120(9), 3127-3136 (2010).
76. Chamberlain SJ, Chen PF, Ng KY et al. Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proc. Natl Acad. Sci. USA 107(41), 17668-17673 (2010).
77. Polychronakos C, Li Q. Understanding Type 1 diabetes through genetics: Advances and prospects. Nat. Rev. Genet. 12(11), 781-792 (2011).
78. Billings LK, Florez JC. The genetics of Type 2 diabetes: What have we learned from GWAS? Ann. NY Acad. Sci. 1212, 59-77 (2010).
79. Maehr R. iPS cells in Type 1 diabetes research and treatment. Clin. Pharmacol. Ther. 89(5), 750-753 (2011).
80. Melton DA. Using stem cells to study and possibly treat Type 1 diabetes. Philos. Trans. R. Soc. Lond. B Biol. Sci. 366(1575), 2307-2311 (2011).
81. Huang P, He Z, Ji S et al. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 475(7356), 386-389 (2011).
82. Jiang J, Au M, Lu K et al. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 25(8), 1940-1953 (2007). (Pubitemid 47258172)
83. Xu X, Browning VL, Odorico JS. Activin, BMP and FGF pathways cooperate to promote endoderm and pancreatic lineage cell differentiation from human embryonic stem cells. Mech. Dev. 128(7-10), 412-427 (2011).